Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-064129

BIOLASE, INC · BIOL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Harold C Flynn Jr.
Officer — President and CEO · Director
Period of report
Dec 5, 2017
Accepted (ET)
Dec 6, 2017 · 11:16 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 5, 2017X65,870$0.456A131,970IBy Trust
Common Stockholding———96,720D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Subscription Rights (Right to Buy)F2,F3$0.456Dec 5, 2017X65,870DNov 8, 2017Nov 29, 2017Common Stock65,8700I

Explanation of responses